Cite
APA Citation
Caffo, O., Lo Re, G., Sava, T., Buti, S., Sacco, C., Basso, U., Zustovich, F., Lodde, M., Perin, A., Facchini, G., Veccia, A., Maines, F., Barile, C., Fratino, L., Gernone, A., De Vivo, R., Pappagallo, G. L., & Galligioni, E. (2015). intermittent docetaxel chemotherapy as first-line treatment for metastatic castration-resistant prostate cancer patients. Future oncology, 11, 965–973. http://access.bl.uk/ark:/81055/vdc_100146750872.0x000029